These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37097850)

  • 1. Publishing the Biotechnical Futures of Alzheimer's Disease.
    Fletcher JR
    AJOB Neurosci; 2023; 14(2):124-126. PubMed ID: 37097850
    [No Abstract]   [Full Text] [Related]  

  • 2. Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer's Disease and Related Disorders.
    Carter A; Graham M; Hall W; Barber M; Gardner J
    AJOB Neurosci; 2023; 14(2):129-131. PubMed ID: 37097862
    [No Abstract]   [Full Text] [Related]  

  • 3. Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer's Disease and Related Dementias.
    Peterson A; Largent EA; Lynch HF; Karlawish J; Sisti D
    AJOB Neurosci; 2023; 14(2):107-123. PubMed ID: 36476106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer's Disease and Related Dementias.
    Rudolph KA
    AJOB Neurosci; 2023; 14(2):136-138. PubMed ID: 37097843
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer's--good news?
    Schmidt-Nielson K
    N C Med J; 1995 Apr; 56(4):135-6. PubMed ID: 7661951
    [No Abstract]   [Full Text] [Related]  

  • 6. Some ethnopharmacological notes on African hallucinogens.
    De Smet PA
    J Ethnopharmacol; 1996 Mar; 50(3):141-6. PubMed ID: 8691848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imagining a Role for Psychedelics in Dementia Care.
    George DR; Hanson R
    Am J Geriatr Psychiatry; 2019 Sep; 27(9):1028-1030. PubMed ID: 31047789
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care.
    Soofi H; Forlini C
    AJOB Neurosci; 2023; 14(2):131-134. PubMed ID: 37097855
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrine for Alzheimer's disease.
    Wolferman A
    JAMA; 1994 Dec; 272(24):1896; author reply 1897-8. PubMed ID: 7990233
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrine for Alzheimer's disease.
    Temianka D
    JAMA; 1994 Dec; 272(24):1896-7; author reply 1897-8. PubMed ID: 7990234
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease. Three-score years and then?
    Bryan J
    Health Serv J; 1998 Aug; 108(5619):suppl 4-5, 7-8. PubMed ID: 10185456
    [No Abstract]   [Full Text] [Related]  

  • 12. Journey to Narayama: Cultural Complexities, Psychedelics and Dementia.
    Ozeki-Hayashi R; Wilkinson DJ
    AJOB Neurosci; 2023; 14(2):145-147. PubMed ID: 37097874
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and future treatments for Alzheimer's disease.
    Salloway S
    CNS Spectr; 2009 Aug; 14(8 Suppl 7):4-7; discussion 16-8. PubMed ID: 19890240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Alzheimer's disease research.
    Khachaturian ZS; Monjan AA; Radebaugh TS
    Prog Clin Biol Res; 1989; 317():13-21. PubMed ID: 2690097
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's disease beyond amyloid: strategies for future therapeutic interventions.
    Shi J; Sabbagh MN; Vellas B
    BMJ; 2020 Oct; 371():m3684. PubMed ID: 33036984
    [No Abstract]   [Full Text] [Related]  

  • 16. Conquering Alzheimer's: a look at the therapies of the future.
    Abbott A
    Nature; 2023 Apr; 616(7955):26-28. PubMed ID: 37016121
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Alzheimer's disease with cholinesterase inhibitors.
    Schneider LS
    Clin Geriatr Med; 2001 May; 17(2):337-58. PubMed ID: 11375139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's associated inflammation, potential drug targets and future therapies.
    Stuchbury G; Münch G
    J Neural Transm (Vienna); 2005 Mar; 112(3):429-53. PubMed ID: 15723159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tetrahydroaminoacridine or THA. Disputed value in Alzheimer's type dementia].
    Chatellier G
    Rev Prat; 1993 Mar; 43(6):725-8. PubMed ID: 8341950
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's drug saga prompts journal to scrutinize whistle-blowers.
    Else H
    Nature; 2023 Jan; 613(7945):618-619. PubMed ID: 36639445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.